Integra LifeSciences Holdings Corporation
IART
$14.05
-$0.14-0.99%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 415.61M | 382.65M | 442.65M | 380.83M | 418.18M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 415.61M | 382.65M | 442.65M | 380.83M | 418.18M |
| Cost of Revenue | 186.41M | 167.51M | 176.80M | 162.79M | 167.39M |
| Gross Profit | 229.19M | 215.15M | 265.84M | 218.04M | 250.78M |
| SG&A Expenses | 171.06M | 159.55M | 172.92M | 164.94M | 175.72M |
| Depreciation & Amortization | 3.75M | 3.70M | 3.72M | 3.76M | 3.71M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 382.93M | 351.17M | 378.33M | 355.71M | 371.00M |
| Operating Income | 32.67M | 31.48M | 64.32M | 25.13M | 47.17M |
| Income Before Tax | -530.95M | -30.04M | 22.54M | -20.36M | -15.19M |
| Income Tax Expenses | -46.88M | -4.74M | 3.11M | -9.67M | -2.78M |
| Earnings from Continuing Operations | -484.07M | -25.29M | 19.44M | -10.70M | -12.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -484.07M | -25.29M | 19.44M | -10.70M | -12.40M |
| EBIT | 32.67M | 31.48M | 64.32M | 25.13M | 47.17M |
| EBITDA | 70.37M | 68.67M | 109.01M | 46.89M | 76.85M |
| EPS Basic | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 |
| Normalized Basic EPS | 0.13 | 0.15 | 0.40 | 0.11 | 0.29 |
| EPS Diluted | -6.31 | -0.33 | 0.25 | -0.14 | -0.16 |
| Normalized Diluted EPS | 0.13 | 0.15 | 0.40 | 0.11 | 0.29 |
| Average Basic Shares Outstanding | 76.70M | 76.46M | 76.42M | 76.45M | 77.41M |
| Average Diluted Shares Outstanding | 76.70M | 76.46M | 76.42M | 76.45M | 77.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |